Preparing for China · patient guide

Medication review for older adults in China: what to expect

A medication review in China is a clinician-led appointment, usually with a geriatrician, general physician or clinical pharmacist, that examines every medicine an older adult takes, including prescriptions, over-the-counter products and supplements. The clinician decides whether any change is appropriate. Expect to supply a complete medicine list and recent test results, and to confirm with the specific hospital how the review is arranged, who leads it and what it costs.

Go to the practical guidance ↓
AI illustration: A doctor consulting with an elderly couple at a round table in a bright room with plants.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a medication review actually is, and what it is not

A medication review is a structured conversation and clinical assessment, not a single test. The clinician looks at what the older person takes, why each item was started, whether the dose still matches the person's age, kidney and liver function, weight and other conditions, and whether different medicines or supplements might interact. Symptoms such as dizziness, falls, confusion, drowsiness, constipation or poor appetite can sometimes relate to medicines, so the review usually includes the patient's own account of how they feel and how daily life is affected.

It is not a prescription-refill service and it is not a guarantee that medicines will be reduced. A responsible review can conclude that the current regimen is appropriate, that one item should be adjusted, that monitoring is needed, or that a specialist opinion is required first. Decisions about stopping, switching or reducing a medicine belong to the treating clinician who has the full picture, and some medicines should not be stopped abruptly. If the older person is acutely unwell, confused, has fallen with injury or has trouble breathing, that needs urgent local assessment rather than a planned overseas appointment.

For families considering care in China, the practical question is usually narrower: can a clinician here review a complex regimen and give a clear written opinion the home team can act on? That depends on the records available, the clinician's assessment and the hospital's own arrangements, so it is worth confirming before booking travel.

Who leads the review in China, and how to ask

Medication reviews for older adults can sit with different professionals: a geriatrician, a general internal medicine physician, a clinical pharmacist working with a physician, or a specialist managing the condition that prompted a particular drug. Which route fits depends on the main problem. A person with many conditions and repeated falls may suit a geriatric assessment; someone whose concern centres on heart or kidney medicines may need that specialty. Rather than assuming one department, describe the situation and ask which clinician the hospital would assign.

China's larger tertiary hospitals are busy, and appointment systems, department structures and language support differ between public tertiary hospitals and private international clinics. Do not assume that a walk-in review is possible or that an English-speaking pharmacist is available. Ask directly: who will conduct the review, whether it is physician-led or pharmacist-led, how long the appointment is expected to take, whether an interpreter is provided or must be arranged separately, and whether a written summary in English can be produced. These are administrative questions the hospital must answer, not facts that can be assumed from a website.

If the family cannot travel first, a records-based opinion may be an option, but it has limits: without examining the patient and without current blood tests, a clinician can comment on the regimen but may not be able to make final decisions. Ask what the clinician can and cannot conclude from records alone.

The records that make a review useful

The quality of a medication review depends heavily on what the clinician can see. A complete, current medicine list is the starting point, and it should include the exact name, dose, frequency, timing and route for each item, plus who prescribed it and when it began. Include everything, not only prescribed drugs: over-the-counter painkillers, sleep aids, laxatives, inhalers, eye drops, patches, injections, vitamins, herbal products and anything bought online. Traditional Chinese medicine and supplements matter because they can interact with other medicines, and the clinician needs to know about them rather than have them left off the list.

Recent results help the clinician judge whether doses remain appropriate, particularly kidney and liver function, blood counts, electrolytes and any drug-level monitoring. Bring the actual reports rather than a summary, along with a list of diagnoses, allergies and previous reactions to medicines, and notes on recent hospital admissions or falls. A short diary of symptoms, timing of doses and any side effects the family has noticed can be more useful than a long narrative.

Records in another language are common. Ask the hospital in advance whether translated summaries are needed, who is responsible for translation, and whether the original documents should also be brought. Do not send a full medical archive in a first enquiry; a brief summary and the main question are enough to start, and the hospital or coordinator can then say which documents are relevant.

  • Current medicine list with exact names, doses, times and prescriber
  • Recent blood tests, including kidney and liver function where available
  • Diagnoses, allergies and any previous adverse drug reactions
  • Notes on falls, confusion, dizziness or other symptoms and when they occur
  • Names of the clinicians at home who currently manage the medicines

What happens during the appointment

A well-run review usually starts with the patient's own priorities: what worries them most, which symptoms they have noticed, and what they want from the visit. The clinician will then work through the medicine list, checking the reason for each item, the dose, the duration and whether the expected benefit still outweighs the burden for this person. Questions about swallowing difficulties, timing around meals, cost and whether the person can actually manage the regimen at home are part of a practical review, not an afterthought.

The clinician may ask for blood tests or other checks before making a decision, and may want to speak with the family or the home prescriber. Some changes can be discussed and agreed during the visit; others need monitoring over time, and the clinician may recommend a follow-up plan rather than a single decisive change. Ask for the reasoning in writing: which medicines are being continued, which are being adjusted and why, what monitoring is needed, and which symptoms should prompt urgent contact.

Families should be ready for the possibility that the clinician recommends no change, or recommends that a decision be made by the original prescriber with the full history. That is a legitimate outcome, not a failed appointment. The value of the review lies in a careful, documented assessment, not in a guaranteed reduction in the number of medicines.

Safety boundaries families should understand

Medication changes carry real risks, especially in older adults whose kidney function, balance and thinking can be affected by small dose changes. A review conducted in China does not automatically transfer to the home system: the medicines available, their formulations and the monitoring arrangements may differ, and the clinician who prescribed the original regimen still needs to know about any recommendation. Ask how the Chinese clinician would communicate with the home team, and whether they are willing to provide a written opinion that the family can take back.

Do not stop or change any medicine on the basis of a website, a coordinator's suggestion or a preliminary comment before the treating clinician has made a decision. If a medicine is causing an urgent problem such as severe drowsiness, breathing difficulty, a serious fall or signs of an allergic reaction, seek local emergency care rather than waiting for an appointment. Herbal products and supplements are not automatically safe alongside prescription medicines, and cross-border rules about carrying medicines differ; questions about what may be brought into or out of China belong to customs and the relevant authorities, not to a coordination service.

It is also reasonable to ask the clinician about the evidence behind a proposed change, the expected risks and benefits for this individual, and what alternatives exist. A clinician can discuss these estimates without guaranteeing an outcome.

Practical planning and the next step

Before committing to travel, confirm the essentials in writing: which hospital and clinician would see the patient, whether the review is a single appointment or a series, what records are required, how interpretation is handled, and what the hospital's own charges are. Hospital consultation and test fees are paid to the hospital, while any coordination or interpretation service is separate and agreed in advance. Ask for the actual written scope rather than relying on a general description, since what is included can differ between providers.

Consider whether the older person can manage the journey and the appointment, and whether a family member or carer should attend. If the main aim is a second opinion on a complex regimen, a records-based review may be a sensible first step, but it is optional and not a prerequisite for an appointment. An initial enquiry with ChinaSpecialistCare is free: share a brief summary of the situation and the main question, and the team can indicate which records are relevant and what the next step might be. The treating hospital decides whether a review is suitable and what it recommends.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Traditional Chinese medicine

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.